• Pyridostatin TFA: G-Quadruplex Research Guide

  2026-09-18

  Pyridostatin TFA is a synthetic G-quadruplex DNA stabilizer for telomere biology and cancer-cell studies. Product data describe preferential growth inhibition in HT1080 fibrosarcoma cells relative to WI-38 fibroblasts, while recent RNA G-quadruplex research supports a separate structure–protein connection that should not be conflated with DNA-targeted Pyridostatin experiments.

• One-step TUNEL Cy3 Apoptosis Detection Kit Guide

  2026-09-18

  Build a defensible DNA fragmentation assay for cultured cells and tissue sections with Cy3 imaging or flow cytometry. This guide translates glioblastoma apoptosis findings into practical controls, workflow decisions, and troubleshooting steps for more reproducible apoptosis research.

• LY294002 Workflow for PI3K/Akt Studies

  2026-09-17

  Build a reproducible LY294002 workflow for mapping PI3K/Akt/mTOR signaling, apoptosis, and autophagy responses. Practical dosing, timing, controls, and troubleshooting help distinguish pathway-specific effects from cytotoxicity and micromolar off-target activity.

• Oltipraz and the Nrf2–Ferroptosis Research Frontier

  2026-09-17

  A translational perspective on how Oltipraz can serve as a chemically defined Nrf2 probe in MASLD and chemoprevention research, using recent QSHXO findings to connect detoxification, autophagy, ferroptosis, and experimental strategy.

• Tetracycline Hydrochloride: Assay Workflows

  2026-09-16

  Build reproducible antimicrobial, ribosome-translation, and skin microbiome experiments with Tetracycline Hydrochloride. This guide pairs concentration-aware preparation and assay controls with a clear boundary between tetracycline workflows and the rapid ROS-based cancer findings reported for carrier-platin.

• Irinotecan CPT-11: From Prodrug to Assay Design

  2026-09-16

  Irinotecan and CPT-11 are best interpreted through a layered framework linking prodrug activation, topoisomerase I damage, and cell fate. This guide converts those mechanisms into practical assay decisions while distinguishing irinotecan evidence from insights borrowed from antiemetic pharmacology.

• Machine Learning Reveals New Senolytics

  2026-09-15

  The reference study shows that conventional machine-learning models trained on published screening data can identify senolytic candidates despite small, heterogeneous datasets. Its validation of ginkgetin, periplocin, and oleandrin illustrates a cost-conscious route from literature curation to cell-based confirmation, while also defining important limits for translating computational predictions into therapy.

• Tomivosertib: MNK1 Inhibitor Workflow

  2026-09-15

  Build a reproducible Tomivosertib workflow around direct MNK1/2 target engagement, phospho-eIF4E validation, and downstream functional assays. The same framework can be adapted to acute myeloid leukemia, glioblastoma, hepatic metabolism, and neuronal hyperactivity while preserving clear controls and troubleshooting checkpoints.

• Linoleic Acid (C18:2) Practical Guide

  2026-09-14

  Linoleic Acid (SKU C3108) provides a defined source of the essential omega-6 fatty acid C18:2(9Z,12Z) for controlled studies of oxidative stress, membrane behavior, erythrocyte injury, migration, and essential fatty acid deficiency. It is intended for solvent-compatible laboratory workflows, not aqueous-only protocols or experiments that require long-term stability of prepared solutions.

• Triamcinolone Protocol and QC Guide

  2026-09-14

  Triamcinolone (SKU B1859) is a research-grade synthetic glucocorticoid agonist for controlled studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses solvent selection, stock handling, assay controls, and interpretation boundaries; the compound is for scientific research only and is not intended for diagnostic, clinical, or therapeutic use.

• RNA G-Quadruplexes Modulate TDP-43 Toxicity

  2026-09-13

  Oldani et al. show that RNA G-quadruplexes directly influence TDP-43 aggregation, cellular distribution, and toxicity across biochemical and cellular models. The work positions G-quadruplex structure as a potential regulatory variable in neurodegeneration research while emphasizing the need to distinguish protective condensation from irreversible protein aggregation.

• HotStart qPCR Master Mix for CRC Assays

  2026-09-12

  Learn how the HotStart Universal 2X FAST Green qPCR Master Mix supports mechanism-driven colorectal cancer gene expression analysis. This guide connects H3K18 lactylation, METTL5, CCT2, and pyroptosis biology to rigorous qPCR assay design and specificity control.

• VX-765: A Causal Map of Inflammasome Assays

  2026-09-11

  VX-765 and its active metabolite VRT-043198 provide a selective way to connect caspase-1 activity with cytokine release and pyroptosis. This guide develops a cell-state-aware assay strategy grounded in CARD8 inflammasome research and practical disease-model applications.

• Batimastat (BB-94) in MMP Assay Workflows

  2026-09-11

  Batimastat (BB-94) converts broad-spectrum MMP inhibition into a practical tool for enzyme assays, matrix-remodeling studies, and cancer-model experiments. This workflow-focused guide also shows how to test the MMP-dependent processing arm of localized BDNF release during neuromuscular-junction development without overstating what the reference study directly demonstrated.

• Verteporfin (CL 318952): Assay Workflows

  2026-09-10

  Verteporfin (CL 318952) supports two complementary experimental modes: light-activated vascular and cellular injury, plus light-independent disruption of p62-associated autophagosome formation. This guide translates those properties into controlled photodynamic therapy, apoptosis, autophagy, and exploratory stem-cell differentiation workflows.

8052 records 1/537 page Next 12345 下5页 Last page